Atossa Genetics Inc. (ATOS) Social Stream
ATOSSA THERAPEUTICS INC (ATOS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ATOSSA THERAPEUTICS INC.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued April 8, 2022
The Trend in the Analyst Price Target
Over the past 15 months, ATOS's average price target has gone down $2.25.
500 - Internal server error
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ATOS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how ATOSSA THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than practically none of that group.
- ATOSSA THERAPEUTICS INC's variance in analysts' estimates is lower than just about 100% of all US stocks.
- In the context of Healthcare stocks, ATOSSA THERAPEUTICS INC's average analyst price target is higher than 16.24% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, ATOSSA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 161.86% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ATOSSA THERAPEUTICS INC are NHWK, ACRX, and IBIO.
What is the outlook for ATOS? Use POWR Ratings for clearer insight into price direction.